Blanca Coll-Vinent1, Alfonso Martín2, Francisco Malagón3, Coral Suero4, Juan Sánchez5, Mercedes Varona6, Manuel Cancio7, Susana Sánchez8, Eugeni Montull9, Carmen Del Arco10. 1. Arrhythmia Division, Spanish Society of Emergency Medicine, Madrid, Spain; Emergency Department, Unitat de Fibrillació Auricular, Hospital Clínic, Barcelona, and Grup de Recerca "Urgències: processos i patologies," IDIBAPS, Barcelona, Spain. Electronic address: bcvinent@clinic.cat. 2. Arrhythmia Division, Spanish Society of Emergency Medicine, Madrid, Spain; Emergency Department, Hospital Universitario Severo Ochoa and University Alfonso X, Madrid, Spain. 3. Arrhythmia Division, Spanish Society of Emergency Medicine, Madrid, Spain; Emergency Department, Hospital Universitario Torrejón, Madrid, Spain. 4. Arrhythmia Division, Spanish Society of Emergency Medicine, Madrid, Spain; Emergency Department, Hospital Universitario Carlos Haya, Málaga, Spain. 5. Arrhythmia Division, Spanish Society of Emergency Medicine, Madrid, Spain; Emergency Department, Hospital Universitario Virgen de las Nieves, Granada, Spain. 6. Arrhythmia Division, Spanish Society of Emergency Medicine, Madrid, Spain; Emergency Department, Hospital de Basurto, Bilbao, Spain. 7. Arrhythmia Division, Spanish Society of Emergency Medicine, Madrid, Spain; Emergency Department, Hospital Donostia, San Sebastián, Spain. 8. Arrhythmia Division, Spanish Society of Emergency Medicine, Madrid, Spain; Emergency Department, Hospital Universitario Río Hortega, Valladolid, Spain. 9. Sanofi-Aventis Spain, Barcelona, Spain. 10. Arrhythmia Division, Spanish Society of Emergency Medicine, Madrid, Spain; Emergency Department, Hospital Universitario La Princesa and Universidad Autónoma, Madrid, Spain.
Abstract
STUDY OBJECTIVE: We determine the prevalence of stroke prophylaxis prescription in emergency department (ED) patients with atrial fibrillation and the factors associated with a lack of prescription of anticoagulation in high-risk patients without contraindications. METHODS: This was a multicenter, observational, cross-sectional study with prospective standardized data collection carried out in 124 Spanish EDs. Clinical variables, risk factors for stroke, type of prophylaxis prescribed, and reasons for not prescribing anticoagulation in high-risk patients (congestive heart failure/left ventricular dysfunction, hypertension, age >75 years, diabetes and previous stroke/transient ischemic attack/systemic embolism [CHADS2] score ≥2 and the congestive heart failure/left ventricular dysfunction, hypertension, age >75 years, diabetes, previous stroke/transient ischemic attack/systemic embolism, vascular disease age 65 to 74 years and sex category [CHA2DS2-VASc] score ≥2) without contraindications were collected. RESULTS: Of 3,276 patients enrolled, 71.5% were at high risk according to CHADS2; 89.7% according to CHA2DS2-VASc. At discharge from the ED, 2,255 patients (68.8%) were receiving anticoagulants, 1,691 of whom (75%) were high-risk patients. Of the 1,931 patients discharged home, anticoagulation was prescribed for 384 patients (19.9%) de novo and for 932 patients (48.3%) previously receiving anticoagulation. The main reasons for not prescribing anticoagulation to eligible patients were considering antiplatelet therapy as adequate prophylaxis (33.1%), advanced age (15%), and considering stroke risk as low (8.3%). Advanced age (odds ratio 0.46; 95% confidence interval 0.30 to 0.69) and female sex (odds ratio 0.50; 95% confidence interval 0.36 to 0.71) were significantly associated with the lack of prescription of anticoagulation to eligible patients. CONCLUSION: In Spain, most patients with atrial fibrillation treated in EDs who do not receive anticoagulation are at high risk of stroke, with relevant differences with regard to the risk stratification scheme used. Anticoagulation is underused, mainly because the risk of stroke is underestimated by the treating physicians and the benefits of antiplatelets are overrated, principally in female patients and the elderly. Efforts to increase the prescription of anticoagulation in these patients appear warranted.
STUDY OBJECTIVE: We determine the prevalence of stroke prophylaxis prescription in emergency department (ED) patients with atrial fibrillation and the factors associated with a lack of prescription of anticoagulation in high-risk patients without contraindications. METHODS: This was a multicenter, observational, cross-sectional study with prospective standardized data collection carried out in 124 Spanish EDs. Clinical variables, risk factors for stroke, type of prophylaxis prescribed, and reasons for not prescribing anticoagulation in high-risk patients (congestive heart failure/left ventricular dysfunction, hypertension, age >75 years, diabetes and previous stroke/transient ischemic attack/systemic embolism [CHADS2] score ≥2 and the congestive heart failure/left ventricular dysfunction, hypertension, age >75 years, diabetes, previous stroke/transient ischemic attack/systemic embolism, vascular disease age 65 to 74 years and sex category [CHA2DS2-VASc] score ≥2) without contraindications were collected. RESULTS: Of 3,276 patients enrolled, 71.5% were at high risk according to CHADS2; 89.7% according to CHA2DS2-VASc. At discharge from the ED, 2,255 patients (68.8%) were receiving anticoagulants, 1,691 of whom (75%) were high-risk patients. Of the 1,931 patients discharged home, anticoagulation was prescribed for 384 patients (19.9%) de novo and for 932 patients (48.3%) previously receiving anticoagulation. The main reasons for not prescribing anticoagulation to eligible patients were considering antiplatelet therapy as adequate prophylaxis (33.1%), advanced age (15%), and considering stroke risk as low (8.3%). Advanced age (odds ratio 0.46; 95% confidence interval 0.30 to 0.69) and female sex (odds ratio 0.50; 95% confidence interval 0.36 to 0.71) were significantly associated with the lack of prescription of anticoagulation to eligible patients. CONCLUSION: In Spain, most patients with atrial fibrillation treated in EDs who do not receive anticoagulation are at high risk of stroke, with relevant differences with regard to the risk stratification scheme used. Anticoagulation is underused, mainly because the risk of stroke is underestimated by the treating physicians and the benefits of antiplatelets are overrated, principally in female patients and the elderly. Efforts to increase the prescription of anticoagulation in these patients appear warranted.
Authors: Bory Kea; Tahroma Alligood; Cassandra Robinson; Josephine Livingston; Benjamin C Sun Journal: Ann Emerg Med Date: 2019-05-09 Impact factor: 5.721
Authors: Oriol Yuguero; Irene Cabello; María Arranz; Jorge-Alexis Guzman; Anna Moreno; Paloma Frances; Julia Santos; Anna Esquerrà; Alvaro Zarauza; Josep-Maria Mòdol; Javier Jacob Journal: Intern Emerg Med Date: 2021-10-22 Impact factor: 3.397
Authors: Sophie Gupta; Martin Lutnik; Jan Niederdöckl; Sebastian Schnaubelt Journal: Int J Environ Res Public Health Date: 2022-04-15 Impact factor: 4.614
Authors: David R Vinson; E Margaret Warton; Dustin G Mark; Dustin W Ballard; Mary E Reed; Uli K Chettipally; Nimmie Singh; Sean Z Bouvet; Bory Kea; Patricia C Ramos; David S Glaser; Alan S Go Journal: West J Emerg Med Date: 2018-02-12
Authors: Blanca Coll-Vinent; Alfonso Martín; Juan Sánchez; Juan Tamargo; Coral Suero; Francisco Malagón; Mercedes Varona; Manuel Cancio; Susana Sánchez; José Carbajosa; José Ríos; Georgina Casanovas; Carles Ràfols; Carmen Del Arco Journal: Stroke Date: 2017-04-07 Impact factor: 7.914
Authors: Bory Kea; Bethany T Waites; Amber Lin; Merritt Raitt; David R Vinson; Niroj Ari; Luke Welle; Andrew Sill; Dana Button; Benjamin C Sun Journal: West J Emerg Med Date: 2020-06-29